AzTrials
AzTrials

Cardiovascular DiseasePhase 1SAWYESNCT01667835

South Asian Women & Yoga Education Study

A Phase 1 study testing Yoga Intervention in people with Cardiovascular Disease, run by Kwantlen Polytechnic University at 2 sites in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Read more about this study

Who is it for?
Ages 40 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Cardiovascular Disease
What is being tested?
Yoga Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
2 sitesCanada
Study dates
Nov 2012to Aug 2015
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 40- 65 years old
  • Postmenopausal (amenorrhea for ≥ 12 months)
  • Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
  • Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
  • Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
  • Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.

Who cannot join

  • Have had a period within the last year
  • Are not between the ages of 40 and 65
  • Have experience with yoga within the last 12 months
  • Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
  • Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
  • Have a severe infectious or other medical illness right now such as pneumonia
Show all 9Show fewer
  • Use medications to lower blood sugar levels
  • Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
  • Regularly use an assistive device (e.g., cane, walker) to walk

Trial locations and contacts

2 sites in 1 country.

Amandah L Hoogbruin, PhD contact

604 599 3144

amandah.hoogbruin@kwantlen.ca

Raymond Dong, FRCPC contact

604 838 8418

raydongheart@gmail.com

Canada2 sites, 2 recruiting
  • The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic

    Surrey, British Columbia, V3T 0G9

    Amandah L Hoogbruin, PhD, 604 599 3144, amandah.hoogbruin@kwantlen.ca

    Raymond Dong, FRCP(c), 604 686 6372, raydongheart@gmail.com

    Recruiting
  • Kwantlen Polytechnic University

    Surrey, British Columbia, V3W 2M8

    Amandah L Hoogbruin, PhD, 604 599 3144, amandah.hoogbruin@kwantlen.ca

    Raymond Dong, FRCPC, 604 838 8418, raydongcardio@gmail.com

    Not yet recruiting

Other trials in Canada

About this study

Official title: Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Being tested
Yoga Intervention
Keywords
yoga, postmenopausal, sedentary South Asian women
Medical subject headings
Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Yoga InterventionBehavioural

    12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Study groups in NCT01667835
Study groupRoleWhat they receive
Yoga InterventionExperimentalNot described
Receives: Behavioral: Yoga Intervention
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in blood pressure

    blood pressure is measured as a specific physiologic index of cardiovascular risk.

    Measured: baseline, at end of study (12 wks), & 3 months post-study

Secondary outcomes (13)
  1. Change in subjective well-being

    The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.

    Measured: baseline, at end of study (12 wks), & 3 months post-study

  2. Change in perceived physical well-being

    Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being

    Measured: baseline, end of study (12 wks) & 3 months post-study

  3. Change in insulin sensitivity

    Fasting insulin \& glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  4. Change in inflammation

    C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  5. Change in serum total cholesterol

    Serum total cholesterol will be measured as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  6. Change in serum high-density lipoprotein (HDL) cholesterol

    Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  7. Change in serum low-density lipoprotein (LDL) cholesterol

    Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  8. Change in serum triglycerides

    Serum triglycerides will be measured as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  9. Change in waist circumference.

    Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  10. Change waist-hip ratio

    Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  11. Change in body mass index (BMI)

    Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  12. Change in resting heart rate

    Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk

    Measured: baseline, end of study (12 wks) & 3 months post-study

  13. Change in heart rate

    Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk

    Measured: baseline, at end of study (12 wks), & 3 months post-study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2012 (estimated)
  2. Study startNov 2012
  3. Primary completionDec 2014 (estimated)
  4. Study completionAug 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01667835
Sponsor's protocol ID
KK11-04
Acronym
SAWYES
Status last verified
Nov 2012
First submitted
17 Jun 2012
Last updated
19 Nov 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Yoga Intervention in people with Cardiovascular Disease, run by Kwantlen Polytechnic University at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Nov 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Amandah L Hoogbruin, PhD (604 599 3144, amandah.hoogbruin@kwantlen.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in blood pressure (time frame: baseline, at end of study (12 wks), & 3 months post-study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in